FindTrial
Sign In

Effects of Yoga and Ayurveda Treatment for menstrual irregularities in women with mental illness on medications

Effectiveness of Integrated Yoga and Ayurveda Treatment(IYAT) for menstrual irregularities in women with major mental illness on Psychotropics- A Prospective Pre- post Observational study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/12/038968
Enrollment
30
Registered
2021-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E20-E35- Disorders of other endocrine glands Health Condition 2: F30-F39- Mood [affective] disorders Health Condition 3: F20- Schizophrenia

Interventions

None listed

Sponsors

NIMHANS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with menstrual irregularities for past six months on psychotropic medications Stable dose of Psychotropic medication for the past eight weeks Patients willing to give an informed consent

Exclusion criteria

Exclusion criteria: Patients taking medications from a Gynaecologist for the menstrual complaints Pregnant and lactating women Patients contraindicated for Kapalabhati like Hypertension, Seizure disorder, low back ache, glaucoma, recent abdominal surgery, hernia Patients not willing to give an informed consent

Design outcomes

Primary

MeasureTime frame
Menstrual frequency at baseline Changes in anthropometry,BMI, BMR and body fat percentageTimepoint: At baseline, before and after 45 days of IYAT—

Secondary

MeasureTime frame
Fasting blood sugar, lipid profile, Serum Insulin and ProlactinTimepoint: At baseline, before and after 45 days of IYAT—

Countries

India

Contacts

Public ContactHemant Bharghav

National Institute of Mental Health and Neurosciences

hollabharath@gmail.com9844259459

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026